Pooja Jadiya to Caenorhabditis elegans Proteins
This is a "connection" page, showing publications Pooja Jadiya has written about Caenorhabditis elegans Proteins.
Connection Strength
1.942
-
Jadiya P, Nazir A. A pre- and co-knockdown of RNAseT enzyme, Eri-1, enhances the efficiency of RNAi induced gene silencing in Caenorhabditis elegans. PLoS One. 2014; 9(1):e87635.
Score: 0.462
-
Jadiya P, Mir SS, Nazir A. Effect of various classes of pesticides on expression of stress genes in transgenic C. elegans model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Dec; 11(8):1001-5.
Score: 0.427
-
Jadiya P, Chatterjee M, Sammi SR, Kaur S, Palit G, Nazir A. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease. Biochem Biophys Res Commun. 2011 Sep 23; 413(2):306-10.
Score: 0.391
-
Jadiya P, Mir SS, Nazir A. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model. Cell Signal. 2018 05; 45:71-80.
Score: 0.153
-
Kumar L. Functional Characterization of Novel Circular RNA Molecule, circzip-2 and Its Synthesizing Gene zip-2 in C. elegans Model of Parkinson's Disease. Mol Neurobiol. 2018 Aug; 55(8):6914-6926.
Score: 0.152
-
Jadiya P, Fatima S, Baghel T, Mir SS, Nazir A. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans. Mol Neurobiol. 2016 11; 53(9):6288-6300.
Score: 0.131
-
Fatima S, Haque R, Jadiya P. Ida-1, the Caenorhabditis elegans orthologue of mammalian diabetes autoantigen IA-2, potentially acts as a common modulator between Parkinson's disease and Diabetes: role of Daf-2/Daf-16 insulin like signalling pathway. PLoS One. 2014; 9(12):e113986.
Score: 0.123
-
Kaur S, Sammi SR, Jadiya P, Nazir A. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans. CNS Neurol Disord Drug Targets. 2012 Jun 01; 11(4):387-94.
Score: 0.103